Your browser doesn't support javascript.
loading
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Janssen, Harry L A; Hou, Jinlin; Asselah, Tarik; Chan, Henry L Y; Zoulim, Fabien; Tanaka, Yasuhito; Janczewska, Ewa; Nahass, Ronald G; Bourgeois, Stefan; Buti, Maria; Lampertico, Pietro; Lenz, Oliver; Verbinnen, Thierry; Vandenbossche, Joris; Talloen, Willem; Kalmeijer, Ronald; Beumont, Maria; Biermer, Michael; Shukla, Umesh.
Afiliação
  • Janssen HLA; Toronto General Hospital, Toronto, Ontario, Canada.
  • Hou J; Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.
  • Asselah T; Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Chan HLY; Université de Paris Cité, INSERM UMR1149, Hôpital Beaujon AP-HP, Clichy, France.
  • Zoulim F; The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Tanaka Y; Hospices Civils de Lyon and Lyon University & INSERM U1052-Cancer Research Institute of Lyon, Lyon, France.
  • Janczewska E; Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan.
  • Nahass RG; Faculty of Health Sciences in Bytom, Medical University of Silesia, Katowice, Poland.
  • Bourgeois S; ID Care, Hillsborough, New Jersey, USA.
  • Buti M; ZNA Jan Palfijn, CPU, Antwerp, Belgium.
  • Lampertico P; Hospital Universitario Vall d'Hebrón and CIBERHED del Instituto Carlos III, Barcelona, Spain.
  • Lenz O; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Verbinnen T; Department of Pathophysiology and Transplantation, CRC 'A. M. and A. Migliavacca' Center for Liver Disease, University of Milan, Milan, Italy.
  • Vandenbossche J; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Talloen W; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Kalmeijer R; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Beumont M; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Biermer M; Janssen Pharmaceuticals R&D, Titusville, New Jersey, USA.
  • Shukla U; Janssen Pharmaceuticals R&D, Titusville, New Jersey, USA.
Gut ; 72(7): 1385-1398, 2023 07.
Article em En | MEDLINE | ID: mdl-36697207
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article